Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 03, 2015 6:58 PM ET


Company Overview of Argolyn Bioscience, Inc.

Company Overview

Argolyn Bioscience, Inc., a biotechnology company, discovers and develops peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. The company’s products are based on amino acid analog substitution technology. The company's products include ABS201 for schizophrenia and ABS212 for pain. Argolyn Bioscience, Inc. was incorporated in 2002 and is based in Durham, North Carolina. Argolyn Bioscience, Inc. is under liquidation.

2530 Meridian Parkway

Suite 200

Durham, NC 27713

United States

Founded in 2002





Key Executives for Argolyn Bioscience, Inc.

Chief Executive Officer and President
Age: 65
Founder and Chief Scientific Officer
Chief Medical Officer and Advisor
Age: 66
Chief Development Officer
Age: 64
Director of Drug Development and Advisor
Age: 60
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
MicroVAX, LLC United States
LEAD Therapeutics, Inc. United States
Cell Targeting Inc. United States
Targeted Growth, Inc. United States
American Type Culture Collection Inc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Argolyn Bioscience, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at